SK282112B6 - Farmaceutický prostriedok s pomalým uvoľňovaním účinnej zložky obsahujúci mizolastín - Google Patents

Farmaceutický prostriedok s pomalým uvoľňovaním účinnej zložky obsahujúci mizolastín Download PDF

Info

Publication number
SK282112B6
SK282112B6 SK1210-98A SK121098A SK282112B6 SK 282112 B6 SK282112 B6 SK 282112B6 SK 121098 A SK121098 A SK 121098A SK 282112 B6 SK282112 B6 SK 282112B6
Authority
SK
Slovakia
Prior art keywords
acid
mizolastine
pharmaceutical composition
composition according
slow
Prior art date
Application number
SK1210-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK121098A3 (en
Inventor
Maryvonne Chariot
Gareth Lewis
Jean Montel
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK121098A3 publication Critical patent/SK121098A3/sk
Publication of SK282112B6 publication Critical patent/SK282112B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1210-98A 1996-03-04 1997-02-28 Farmaceutický prostriedok s pomalým uvoľňovaním účinnej zložky obsahujúci mizolastín SK282112B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602662A FR2745500B1 (fr) 1996-03-04 1996-03-04 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine
PCT/FR1997/000355 WO1997032584A1 (fr) 1996-03-04 1997-02-28 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine

Publications (2)

Publication Number Publication Date
SK121098A3 SK121098A3 (en) 1999-01-11
SK282112B6 true SK282112B6 (sk) 2001-11-06

Family

ID=9489799

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1210-98A SK282112B6 (sk) 1996-03-04 1997-02-28 Farmaceutický prostriedok s pomalým uvoľňovaním účinnej zložky obsahujúci mizolastín

Country Status (35)

Country Link
US (2) US6165507A (es)
EP (1) EP0906101B1 (es)
JP (2) JP2000512617A (es)
KR (1) KR100369888B1 (es)
CN (1) CN1112929C (es)
AR (1) AR006082A1 (es)
AT (1) ATE219365T1 (es)
AU (1) AU725494B2 (es)
BG (1) BG63451B1 (es)
BR (1) BR9707827A (es)
CA (1) CA2247405C (es)
CO (1) CO4780020A1 (es)
CY (1) CY2293B1 (es)
CZ (1) CZ291418B6 (es)
DE (1) DE69713505T2 (es)
DK (1) DK0906101T3 (es)
EE (1) EE03511B1 (es)
ES (1) ES2177942T3 (es)
FR (1) FR2745500B1 (es)
HK (1) HK1017999A1 (es)
HU (1) HU227472B1 (es)
IL (1) IL126050A (es)
IN (1) IN187739B (es)
NO (1) NO315841B1 (es)
NZ (1) NZ331947A (es)
OA (1) OA10854A (es)
PL (1) PL189813B1 (es)
PT (1) PT906101E (es)
RU (1) RU2173997C2 (es)
SK (1) SK282112B6 (es)
TR (1) TR199801574T2 (es)
TW (1) TW491711B (es)
UA (1) UA49004C2 (es)
WO (1) WO1997032584A1 (es)
ZA (1) ZA971830B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10101564A (ja) * 1996-09-27 1998-04-21 Mitsubishi Chem Corp 鼻炎予防及び／又は治療剤
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
EP1322158B1 (en) * 2000-10-02 2012-08-08 USV Ltd. Sustained release pharmaceutical compositions containing metformin and method of their production
US7052706B2 (en) 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
BR0318167A (pt) * 2003-03-04 2006-02-21 Nostrum Pharmaceuticals Inc formulação de liberação controlada contendo um material hidrofóbico como o agente de liberação controlada
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
UY32008A (es) 2008-07-28 2010-02-26 Takeda Pharmaceutical Composición farmacéutica
JP5744412B2 (ja) * 2010-03-26 2015-07-08 テバ製薬株式会社 フロセミド製剤
US20140179712A1 (en) 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JPS62283926A (ja) * 1986-06-02 1987-12-09 Nippon Chemiphar Co Ltd 塩酸ニカルジピン持続性組成物
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤

Also Published As

Publication number Publication date
ZA971830B (en) 1997-09-04
AU725494B2 (en) 2000-10-12
AR006082A1 (es) 1999-08-11
AU1930097A (en) 1997-09-22
KR100369888B1 (ko) 2003-05-17
SK121098A3 (en) 1999-01-11
CA2247405A1 (en) 1997-09-12
IL126050A (en) 2004-05-12
PT906101E (pt) 2002-09-30
NO984035L (no) 1998-10-22
HUP9902458A2 (hu) 2000-05-28
CZ291418B6 (cs) 2003-03-12
BG102692A (en) 1999-04-30
EP0906101B1 (fr) 2002-06-19
US6165507A (en) 2000-12-26
CN1112929C (zh) 2003-07-02
DK0906101T3 (da) 2002-10-14
NZ331947A (en) 2000-03-27
EE9800275A (et) 1999-02-15
JP2000512617A (ja) 2000-09-26
CA2247405C (en) 2004-04-20
UA49004C2 (uk) 2002-09-16
KR19990087387A (ko) 1999-12-27
BR9707827A (pt) 1999-07-27
NO984035D0 (no) 1998-09-02
EP0906101A1 (fr) 1999-04-07
IL126050A0 (en) 1999-05-09
BG63451B1 (bg) 2002-02-28
NO315841B1 (no) 2003-11-03
CN1212624A (zh) 1999-03-31
DE69713505T2 (de) 2003-02-13
TR199801574T2 (xx) 1998-11-23
TW491711B (en) 2002-06-21
CO4780020A1 (es) 1999-05-26
HU227472B1 (en) 2011-07-28
CZ279198A3 (cs) 1999-01-13
ATE219365T1 (de) 2002-07-15
FR2745500A1 (fr) 1997-09-05
DE69713505D1 (de) 2002-07-25
RU2173997C2 (ru) 2001-09-27
EE03511B1 (et) 2001-10-15
OA10854A (fr) 2003-02-05
HK1017999A1 (en) 1999-12-10
JP2007182451A (ja) 2007-07-19
ES2177942T3 (es) 2002-12-16
HUP9902458A3 (en) 2002-11-28
PL328763A1 (en) 1999-02-15
FR2745500B1 (fr) 1998-04-03
WO1997032584A1 (fr) 1997-09-12
PL189813B1 (pl) 2005-09-30
US20050202089A1 (en) 2005-09-15
CY2293B1 (en) 2003-07-04
IN187739B (es) 2002-06-15

Similar Documents

Publication Publication Date Title
US7618649B2 (en) Extended release oral dosage composition
US6652882B1 (en) Controlled release formulation containing bupropion
RU2303440C2 (ru) Стабильная пероральная дозированная композиция пролонгированного действия
JP2007182451A (ja) ミゾラスチンを含有する徐放性医薬製剤
KR20070053221A (ko) 항-히스타민성 조성물
EP1158963B1 (en) Controlled-release compositions of betahistine
WO1994022435A1 (en) A new composition containing selegiline
WO2011000518A1 (en) Pharmaceutical composition comprising desloratadine
US5817336A (en) Composition containing selegiline
WO2024144207A1 (en) Sustained-release tablet comprising apixaban
US20050074494A1 (en) Itraconazole immediate release formulation
WO2024162929A1 (en) A controlled release formulation of propiverine
SK90894A3 (en) Solid drug forms with reliable releasing active substance of alprazolam and preparation method thereof

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20170228